Literature DB >> 1597517

Immunophenotype of multinucleated and mononuclear cells in giant cell lesions of bone and soft tissue.

I A Doussis1, B Puddle, N A Athanasou.   

Abstract

AIMS: To compare the antigenic phenotype of giant cells in giant cell lesions of bone and soft tissue with that of osteoclasts and macrophage polykaryons.
METHODS: Formalin fixed, paraffin wax embedded sections of 106 giant cell lesions, 19 granulomatous, and 14 osteoclast containing lesions were immuno-histochemically stained for leucocyte common antigen (LCA), CD68, and HLA-DR.
RESULTS: Osteoclasts and giant cells of giant cell tumour of bone and giant cell reparative granuloma could be distinguished by their generalised absence of HLA-DR reaction from macrophage polykaryons and giant cells in other giant cell lesions of bone and soft tissue. Staining for LCA, CD68, and HLA-DR was useful in distinguishing reactive histiocytic giant cells and osteoclasts from tumour giant cells.
CONCLUSIONS: A panel of macrophage associated antigens should be diagnostically useful in differentiating the histological nature of giant cells in various giant cell lesions of bone and soft tissue.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1597517      PMCID: PMC495300          DOI: 10.1136/jcp.45.5.398

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  20 in total

1.  Immunophenotypic differences between osteoclasts and macrophage polykaryons: immunohistological distinction and implications for osteoclast ontogeny and function.

Authors:  N A Athanasou; J Quinn
Journal:  J Clin Pathol       Date:  1990-12       Impact factor: 3.411

2.  Resorption of bone by inflammatory cells derived from the joint capsule of hip arthroplasties.

Authors:  N A Athanasou; J Quinn; C J Bulstrode
Journal:  J Bone Joint Surg Br       Date:  1992-01

3.  Use of monoclonal antibodies to recognise osteoclasts in routinely processed bone biopsy specimens.

Authors:  N A Athanasou; B Puddle; J Quinn; C G Woods
Journal:  J Clin Pathol       Date:  1991-08       Impact factor: 3.411

4.  Non-osteogenic fibroma of bone.

Authors:  H L Jaffe; L Lichtenstein
Journal:  Am J Pathol       Date:  1942-03       Impact factor: 4.307

5.  HLA-DR antigen detection in giant cell lesions.

Authors:  J A Regezi; R J Zarbo; R V Lloyd
Journal:  J Oral Pathol       Date:  1986-09

6.  Effect of decalcification agents on immunoreactivity of cellular antigens.

Authors:  N A Athanasou; J Quinn; A Heryet; C G Woods; J O McGee
Journal:  J Clin Pathol       Date:  1987-08       Impact factor: 3.411

7.  Ultrastructure and histogenesis of giant-cell tumor of bone.

Authors:  H Hanaoka; B Friedman; R P Mack
Journal:  Cancer       Date:  1970-06       Impact factor: 6.860

8.  The effects of calcium regulating hormones on bone resorption by isolated human osteoclastoma cells.

Authors:  T J Chambers; K Fuller; P M McSheehy; J A Pringle
Journal:  J Pathol       Date:  1985-04       Impact factor: 7.996

9.  The cytogenesis of macrophages and osteoclast-like giant cells in bone tumors with special emphasis on the so-called fibrohistiocytic tumors.

Authors:  A Roessner; E Vollmer; G Zwadlo; C Sorg; M Kolve; D B von Bassewitz; P Wuisman; A Härle; E Grundmann
Journal:  Curr Top Pathol       Date:  1989

10.  Bone resorption by macrophage polykaryons of giant cell tumour of tendon sheath.

Authors:  N A Athanasou; J Quinn; D J Ferguson; J O McGee
Journal:  Br J Cancer       Date:  1991-04       Impact factor: 7.640

View more
  11 in total

Review 1.  Foreign body reaction to biomaterials.

Authors:  James M Anderson; Analiz Rodriguez; David T Chang
Journal:  Semin Immunol       Date:  2007-12-26       Impact factor: 11.130

2.  Localized immunosuppressive environment in the foreign body response to implanted biomaterials.

Authors:  David M Higgins; Randall J Basaraba; April C Hohnbaum; Eric J Lee; David W Grainger; Mercedes Gonzalez-Juarrero
Journal:  Am J Pathol       Date:  2009-06-15       Impact factor: 4.307

3.  Immunophenotype of multinucleated cells in giant cell lesions.

Authors:  K Metze
Journal:  J Clin Pathol       Date:  1993-02       Impact factor: 3.411

4.  Erdheim-Chester disease with epiphyseal and systemic disease.

Authors:  N A Athanasou; C Barbatis
Journal:  J Clin Pathol       Date:  1993-05       Impact factor: 3.411

5.  Association of HLA-DRB1 alleles with giant cell tumour of bone.

Authors:  S S Varanasi; N A Athanasou; I Briceno; S S Papiha; H K Datta
Journal:  J Clin Pathol       Date:  1999-10       Impact factor: 3.411

6.  Cep164 is a mediator protein required for the maintenance of genomic stability through modulation of MDC1, RPA, and CHK1.

Authors:  Sudhakar Sivasubramaniam; Xuemin Sun; Yen-Ru Pan; Shaohui Wang; Eva Y-H P Lee
Journal:  Genes Dev       Date:  2008-02-18       Impact factor: 11.361

7.  Giant cell tumor of bone: a neoplasm or a reactive condition?

Authors:  Anwar Ul Haque; Ambreen Moatasim
Journal:  Int J Clin Exp Pathol       Date:  2008-01-01

Review 8.  Giant-cell tumor of bone, anti-RANKL therapy.

Authors:  Armelle Dufresne; Olfa Derbel; Philippe Cassier; Gualter Vaz; Anne-Valérie Decouvelaere; Jean-Yves Blay
Journal:  Bonekey Rep       Date:  2012-09-05

9.  Persistent expression of mitogenic/transforming factors at the site of failed orthopaedic implants: the impact on immune reactivity.

Authors:  J Bainbridge; N Al-Saffar
Journal:  J Mater Sci Mater Med       Date:  1998-12       Impact factor: 3.896

10.  Electrospun micro- and nanofiber tubes for functional nervous regeneration in sciatic nerve transections.

Authors:  Silvia Panseri; Carla Cunha; Joseph Lowery; Ubaldo Del Carro; Francesca Taraballi; Stefano Amadio; Angelo Vescovi; Fabrizio Gelain
Journal:  BMC Biotechnol       Date:  2008-04-11       Impact factor: 2.563

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.